An increasing number of patients are being diagnosed with conditions such as benign prostatic hyperplasia (BPH), urinary incontinence, kidney stones, and prostate cancer, creating sustained demand for advanced urology devices.
Rising Demand for Products
The product segment held a notable share in 2024, driven by the availability of a broad range of specialized tools designed to diagnose and treat urological conditions with higher precision and less invasiveness. From endoscopes and drainage devices to laser systems and urodynamic equipment, product innovation remains at the core of market expansion. Increasing demand for technologically advanced devices that are integrated with AI or offering robotic-assisted functionalities is pushing manufacturers to focus on quality, safety, and performance.Increasing Prevalence of Urolithiasis
The urolithiasis segment will grow at a decent CAGR during 2025-2034, fueled by the rising incidence of kidney stones and related urinary tract conditions across North America. Dietary habits, dehydration, and sedentary lifestyles are contributing to a growing patient pool requiring intervention for stone removal or management. This segment is benefiting from the shift toward minimally invasive techniques such as laser lithotripsy, ureteroscopy, and shock wave therapies. These methods reduce recovery time and hospital stays, making them highly preferred by both patients and healthcare providers.Hospitals and Clinics to Gain Traction
The hospitals and clinics segment held a significant share in 2024 owing to their critical role in delivering specialized care and performing high-volume urological procedures. Hospitals are often the first point of care for patients with acute or complex urological conditions, which supports a high adoption rate of advanced diagnostic and therapeutic equipment. Clinics, on the other hand, are increasingly integrating outpatient surgical suits and specialized urology practices, expanding the reach of these devices beyond traditional inpatient settings.U.S. to Emerge as a Propelling Region
U.S. urology devices market held a sizeable share in 2024, supported by a well-established healthcare system, strong R&D capabilities, and high awareness of urological health issues. Leading hospitals and ambulatory surgical centers across the U.S. are investing in state-of-the-art equipment to improve procedural accuracy and patient recovery outcomes.Major players in the North America urology devices market are Cook Medical, Olympus Corporation, Teleflex, Ambu, Richard Wolf, Boston Scientific Corporation, NIPRO, Intuitive Surgical, Siemens Healthineers, B. Braun, Coloplast, and Laborie Medical Technologies.
To strengthen their foothold in the North America urology devices market, key companies are deploying a multi-pronged strategy centered on innovation, strategic partnerships, and regional expansion. Many are investing heavily in R&D to bring next-generation products to market - particularly devices that support minimally invasive procedures, enhance patient comfort, and integrate smart technology for real-time monitoring. Collaborations with healthcare providers and academic institutions help accelerate clinical validation and market acceptance.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Companies Mentioned
The key companies profiled in this North America Urology Devices market report include:- Ambu
- B. Braun
- Boston Scientific Corporation
- Coloplast
- Cook Medical
- Intuitive Surgical
- Laborie Medical Technologies
- NIPRO
- Olympus Corporation
- Richard Wolf
- Siemens Healthineers
- Teleflex
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 90 |
Published | September 2025 |
Forecast Period | 2024 - 2034 |
Estimated Market Value ( USD | $ 15.6 Billion |
Forecasted Market Value ( USD | $ 30.9 Billion |
Compound Annual Growth Rate | 7.1% |
Regions Covered | North America |
No. of Companies Mentioned | 13 |